Why are mineralocorticoid receptor antagonists cardioprotective?

por Chai, Wenxia, Danser, A. H. Jan
Publicado em 2006

Juxtaglomerular Cell Phenotypic Plasticity

por Martini, Alexandre Góes, Danser, A. H. Jan
Publicado no High Blood Press Cardiovasc Prev (2017)

Revisiting the Brain Renin-Angiotensin System—Focus on Novel Therapies

por Ren, Liwei, Lu, Xifeng, Danser, A. H. Jan
Publicado no Curr Hypertens Rep (2019)

Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?

por Sun, Yuan, Lu, Xifeng, Danser, A. H. Jan
Publicado no Curr Hypertens Rep (2020)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

por Danser, A.H. Jan, Epstein, Murray, Batlle, Daniel
Publicado no Hypertension (2020)

Is there an internal cardiac renin-angiotensin system?

por Danser, A H Jan, Schalekamp, Maarten A D H
Publicado em 1996

Local Angiotensin Generation and AT(2) Receptor Activation

por Esch, Joep H.M. Van, Danser, A.H. Jan
Publicado no Frontiers in Research of the Renin-Angiotensin System on Human Disease (2007)

The (pro)renin receptor. A decade of research: what have we learned?

por Krop, Manne, Lu, Xifeng, Danser, A.H. Jan, Meima, Marcel E.
Publicado em 2012

Renal Angiotensin-Converting Enzyme Upregulation: A Prerequisite for Nitric Oxide Synthase Inhibition–Induced Hypertension?

por Roksnoer, Lodi C.W., Hoorn, Ewout J., Danser, A.H. Jan
Publicado no J Am Soc Nephrol (2014)

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition

por Danser, A H Jan, Tom, Beril, de Vries, René, Saxena, Pramod R
Publicado em 2000

Response to “Is High Prorenin Level Related to Relative Aldosterone Excess?”

por Tu, Wanzhu, Eckert, George J., Pratt, J. Howard, Danser, A.H. Jan
Publicado no Am J Hypertens (2013)

Headache medication and the COVID-19 pandemic

por MaassenVanDenBrink, Antoinette, de Vries, Tessa, Danser, A. H. Jan
Publicado no J Headache Pain (2020)

Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90

por Filipeanu, Catalin M., de Vries, René, Danser, A.H. Jan, Kapusta, Daniel R.
Publicado em 2010

From ARB to ARNI in Cardiovascular Control

por Uijl, Estrellita, Roksnoer, Lodi C. W., Hoorn, Ewout J., Danser, A. H. Jan
Publicado no Curr Hypertens Rep (2016)

Prorenin anno 2008

por Danser, A. H. Jan, Batenburg, Wendy W., van Esch, Joep H. M., Krop, Manne
Publicado em 2008

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

por Saleh, Langeza, Verdonk, Koen, Visser, Willy, van den Meiracker, Anton H., Danser, A. H. Jan
Publicado no Ther Adv Cardiovasc Dis (2016)

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?

por Mirabito Colafella, Katrina M., Neuman, Rugina I., Visser, Willy, Danser, A. H. Jan, Versmissen, Jorie
Publicado no Basic Clin Pharmacol Toxicol (2019)

Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus: a need for higher doses in diabetics?

por Hollenberg, Norman K., Fisher, Naomi DL, Nussberger, Juerg, Moukarbel, George V., Barkoudah, Ebrahim, Danser, A.H. Jan
Publicado no J Hypertens (2011)

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19

por Wu, Congqing, Ye, Dien, Mullick, Adam E., Li, Zhenyu, Danser, A.H. Jan, Daugherty, Alan, Lu, Hong S.
Publicado no bioRxiv (2020)

Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19

por Wu, Congqing, Ye, Dien, Mullick, Adam E., Li, Zhenyu, Danser, A.H. Jan, Daugherty, Alan, Lu, Hong S.
Publicado no Hypertension (2020)